本文選題：非折疊蛋白反應(yīng) + 阿爾茨海默病��； 參考：《重慶醫(yī)學(xué)》2017年18期

【摘要】：正阿爾茨海默病(AD)是一種年齡相關(guān)的神經(jīng)退行性疾病,給患者帶來(lái)了巨大的心理和身體上的負(fù)擔(dān)。由于人們生活方式的不斷改變,AD的患病人數(shù)飛速上漲,已成為威脅人類健康的一重大疾病,根據(jù)Alzheimer′s Disease International網(wǎng)站給出的統(tǒng)計(jì)數(shù)據(jù),2015年全球有4 680萬(wàn)患者,到2030年將增長(zhǎng)到7 470萬(wàn),而2050年可能上漲到驚人的1.31億。目前就
[Abstract]:Alzheimer's disease (AD) is an age-related neurodegenerative disease that imposes a huge psychological and physical burden on patients. As people's lifestyle changes, the number of people suffering from AD has risen rapidly, and it has become a major threat to human health. According to statistics from the Alzheimer's Disease International website, there were 46.8 million people worldwide in 2015. It will grow to 74.7 million by 2030 and could rise to a staggering 131 million by 2050. Right now.
【作者單位】： 重慶理工大學(xué)藥學(xué)與生物工程學(xué)院;
【基金】：國(guó)家自然科學(xué)基金面上項(xiàng)目(81373459) 重慶市杰出青年基金項(xiàng)目(cstc2014jcyjjq10003) 重慶市研究生創(chuàng)新基金資助的項(xiàng)目(CYS16216)
【分類號(hào)】：R749.16
，

本文編號(hào)：1924422